secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001683168-24-003612
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical prices $4.7M public offering of common stock and warrants at $0.58 per unit
--------------------------------------------------------------------------------

- Gross proceeds ~$4.7M; net proceeds ~$3.84M after placement agent fees and expenses.
- Offering consists of 8.1M shares (or pre-funded warrants) plus Class A and B warrants to buy 8.1M shares each, all at $0.58 per unit.
- Class A warrants expire in 5 years, Class B in 1 year; pre-funded warrants exercisable at $0.001 per share.
- Maxim Group LLC acted as exclusive placement agent with 6.5% cash fee plus $100K expense reimbursement.
- Net proceeds to fund clinical trials, R&D, capex, and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316824003612/0001683168-24-003612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316824003612/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-003612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer